Absent proof these institutions do not believe in anything. That is one reason why they hold trialsand conduct studies. What UCLA said is not something they would likely say about every product they are working on, given the high failure rate of new drugs.
It'd be super interesting to see the success rate of university owned IP partnered with small companies like NW as compared to the same kind of small companies that own their IP outright??